TSO3 (TOS) Stock Price, News & Analysis

Company Overview

TSO3 Inc. engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices worldwide. Its principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States. The company also develops and sells the STERIZONE 125L+ sterilizer, which is designed for terminal sterilization of heat and moisture sensitive medical devices, and is intended for the reprocessing of general instruments, rigid channel instruments, and single/multi-channel rigid endoscopes, as well as short and long single/multi-channel flexible endoscopes. In addition, it provides product development services to medical device manufacturers and others that include hydrogen peroxide and ozone sterilization validation, compatibility testing, medical devices cleaning method development, and medical packaging compatibility verification services. The company was founded in 1998 and is headquartered in Quebec, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: C$0.43 to C$0.43
• 52-Week Range: N/A
• Volume: 76,925 shs
• Average Volume: 235,811 shs
• Market Capitalization: C$40.21 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TOS Stock Analysis - Frequently Asked Questions

How do I buy shares of TSO3?

Shares of TOS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of TSO3 own?

Based on aggregate information from My MarketBeat watchlists, some other companies that TSO3 investors own include Canadian Natural Resources (CNQ), ProMetic Life Sciences (PLI), Canopy Growth (CGC), Maxar Technologies (MAXR), Nemaska Lithium (NMX), Organigram (OGI) and Crescent Point Energy (CPG).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: TSE:TOS
• CUSIP: N/A
• CIK: N/A
• Web: www.tso3.com
• Phone: +1-418-6510003
• Fax: N/A
• Employees: 57
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 894.59
• Current Ratio: 5.44
• Quick Ratio: 3.95

Sales & Book Value

• Annual Sales: C$3.61 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 4.39
• Book Value: C($0.06) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 93,512,000
• Free Float: N/A
• Market Cap: C$40.21 million
• Optionable: Not Optionable
• Beta: N/A